{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:05:27Z","timestamp":1793639127774,"version":"4.5.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04225-5","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T15:08:12Z","timestamp":1741705692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adipose stromal cells increase insulin sensitivity and decrease liver gluconeogenesis in a mouse model of type 1 diabetes mellitus"],"prefix":"10.1186","volume":"16","author":[{"given":"Hsiao-Chi","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-1248","authenticated-orcid":false,"given":"Lee-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"4225_CR1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. Idf Diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"37","key":"4225_CR2","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.2174\/138161211798764825","volume":"17","author":"AM Kampoli","year":"2011","unstructured":"Kampoli AM, Tousoulis D, Briasoulis A, Latsios G, Papageorgiou N, Stefanadis C. Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus. Curr Pharm Des. 2011;17(37):4147\u201358.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"4225_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/dia.2018.0384","volume":"21","author":"NC Foster","year":"2019","unstructured":"Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, et al. State of type 1 diabetes management and outcomes from the t1d exchange in 2016\u20132018. Diabetes Technol Ther. 2019;21(2):66\u201372.","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"4225_CR4","doi-asserted-by":"publisher","first-page":"101418","DOI":"10.1016\/j.disamonth.2022.101418","volume":"69","author":"APP Calimag","year":"2023","unstructured":"Calimag APP, Chlebek S, Lerma EV, Chaiban JT. Diabetic ketoacidosis. Dis Mon. 2023;69(3):101418.","journal-title":"Dis Mon"},{"issue":"1","key":"4225_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5152\/balkanmedj.2015.15123","volume":"32","author":"H Demirci","year":"2015","unstructured":"Demirci H, Cosar R, Ciftci O, Sari IK. Atypical diabetic ketoacidosis: Case report. Balkan Med J. 2015;32(1):124\u20136.","journal-title":"Balkan Med J"},{"key":"4225_CR6","doi-asserted-by":"crossref","unstructured":"Calimag APP, Chlebek S, Lerma EV, Chaiban JT. Diabetic ketoacidosis. Dis Mon 2022:101418.","DOI":"10.1016\/j.disamonth.2022.101418"},{"key":"4225_CR7","doi-asserted-by":"publisher","first-page":"998947","DOI":"10.3389\/fimmu.2022.998947","volume":"13","author":"Y Tao","year":"2022","unstructured":"Tao Y, Jiang Q, Wang Q. Adipose tissue macrophages in remote modulation of hepatic glucose production. Front Immunol. 2022;13:998947.","journal-title":"Front Immunol"},{"issue":"6","key":"4225_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/dmrr.863","volume":"24","author":"FQ Nuttall","year":"2008","unstructured":"Nuttall FQ, Ngo A, Gannon MC. Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant? Diabetes Metab Res Rev. 2008;24(6):438\u201358.","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"4225_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/BJ20141171","volume":"466","author":"KS McCommis","year":"2015","unstructured":"McCommis KS, Finck BN. Mitochondrial pyruvate transport: a historical perspective and future research directions. Biochem J. 2015;466(3):443\u201354.","journal-title":"Biochem J"},{"issue":"1","key":"4225_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nyas.13435","volume":"1411","author":"M Hatting","year":"2018","unstructured":"Hatting M, Tavares CDJ, Sharabi K, Rines AK, Puigserver P. Insulin regulation of gluconeogenesis. Ann N Y Acad Sci. 2018;1411(1):21\u201335.","journal-title":"Ann N Y Acad Sci"},{"key":"4225_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mam.2015.09.003","volume":"46","author":"K Sharabi","year":"2015","unstructured":"Sharabi K, Tavares CD, Rines AK, Puigserver P. Molecular pathophysiology of hepatic glucose production. Mol Aspects Med. 2015;46:21\u201333.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"4225_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, et al. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022;7(1):272.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"4225_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner RC, Sterner RM. Car-t cell therapy: current limitations and potential strategies. Blood Cancer J. 2021;11(4):69.","journal-title":"Blood Cancer J"},{"issue":"2","key":"4225_CR14","first-page":"145","volume":"38","author":"AL McCall","year":"2013","unstructured":"McCall AL, Farhy LS. Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control. Minerva Endocrinol. 2013;38(2):145\u201363.","journal-title":"Minerva Endocrinol"},{"issue":"2","key":"4225_CR15","doi-asserted-by":"publisher","first-page":"151329","DOI":"10.1016\/j.ejcb.2023.151329","volume":"102","author":"A Singh","year":"2023","unstructured":"Singh A, Afshan N, Singh A, Singh SK, Yadav S, Kumar M, Sarma DK, Verma V. Recent trends and advances in type 1 diabetes therapeutics: a comprehensive review. Eur J Cell Biol. 2023;102(2):151329.","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"4225_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/hep.21477","volume":"45","author":"R Higashiyama","year":"2007","unstructured":"Higashiyama R, Inagaki Y, Hong YY, Kushida M, Nakao S, Niioka M, et al. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology. 2007;45(1):213\u201322.","journal-title":"Hepatology"},{"issue":"7","key":"4225_CR17","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1053\/j.gastro.2008.03.015","volume":"134","author":"TK Kuo","year":"2008","unstructured":"Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, Yang VW, Lee OK. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology. 2008;134(7):2111\u201321. 2121 e2111-2113.","journal-title":"Gastroenterology"},{"issue":"12","key":"4225_CR18","doi-asserted-by":"publisher","first-page":"158526","DOI":"10.1016\/j.bbalip.2019.158526","volume":"1864","author":"JS Choi","year":"2019","unstructured":"Choi JS, Chae DS, Ryu HA, Kim SW. Transplantation of human adipose tissue derived-svf enhance liver function through high anti-inflammatory property. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(12):158526.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"6554","key":"4225_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.abh1657","volume":"373","author":"TM Brusko","year":"2021","unstructured":"Brusko TM, Russ HA, Stabler CL. Strategies for durable beta cell replacement in type 1 diabetes. Science. 2021;373(6554):516\u201322.","journal-title":"Science"},{"issue":"2","key":"4225_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1615\/CritRevEukaryotGeneExpr.2015013057","volume":"25","author":"S Han","year":"2015","unstructured":"Han S, Sun HM, Hwang KC, Kim SW. Adipose-derived stromal vascular fraction cells: update on clinical utility and efficacy. Crit Rev Eukaryot Gene Expr. 2015;25(2):145\u201352.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"4225_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.reth.2021.11.005","volume":"18","author":"M Yano","year":"2021","unstructured":"Yano M, Nasti A, Seki A, Ishida K, Yamato M, Inui H, et al. Characterization of adipose tissue-derived stromal cells of mice with nonalcoholic fatty liver disease and their use for liver repair. Regen Ther. 2021;18:497\u2013507.","journal-title":"Regen Ther"},{"issue":"1","key":"4225_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s13287-022-03046-0","volume":"13","author":"LW Chen","year":"2022","unstructured":"Chen LW, Chen PH, Tang CH, Yen JH. Adipose-derived stromal cells reverse insulin resistance through inhibition of m1 expression in a type 2 diabetes mellitus mouse model. Stem Cell Res Ther. 2022;13(1):357.","journal-title":"Stem Cell Res Ther"},{"issue":"7895","key":"4225_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41586-021-04248-x","volume":"602","author":"SV Gearty","year":"2022","unstructured":"Gearty SV, Dundar F, Zumbo P, Espinosa-Carrasco G, Shakiba M, Sanchez-Rivera FJ, et al. An autoimmune stem-like cd8 t cell population drives type 1 diabetes. Nature. 2022;602(7895):156\u201361.","journal-title":"Nature"},{"issue":"6","key":"4225_CR24","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1167\/iovs.04-1340","volume":"46","author":"AJ Barber","year":"2005","unstructured":"Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW, Bronson SK. The ins2akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci. 2005;46(6):2210\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"4225_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s42649-023-00089-2","volume":"53","author":"CS Bae","year":"2023","unstructured":"Bae CS, Lee Y, Ahn T. Therapeutic treatments for diabetes mellitus-induced liver injury by regulating oxidative stress and inflammation. Appl Microsc. 2023;53(1):4.","journal-title":"Appl Microsc"},{"key":"4225_CR26","doi-asserted-by":"crossref","unstructured":"Lai HC, Chen PH, Tang CH, Chen LW. Il-10 enhances the inhibitory effect of adipose-derived stromal cells on insulin resistance\/liver gluconeogenesis by treg cell induction. Int J Mol Sci 2024;25(15).","DOI":"10.3390\/ijms25158088"},{"issue":"4","key":"4225_CR27","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","volume":"50","author":"W Ouyang","year":"2019","unstructured":"Ouyang W, O\u2019Garra A. Il-10 family cytokines il-10 and il-22: from basic science to clinical translation. Immunity. 2019;50(4):871\u201391.","journal-title":"Immunity"},{"issue":"8","key":"4225_CR28","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/icb.2010.105","volume":"88","author":"W Pierson","year":"2010","unstructured":"Pierson W, Liston A. A new role for interleukin-10 in immune regulation. Immunol Cell Biol. 2010;88(8):769\u201370.","journal-title":"Immunol Cell Biol"},{"issue":"8","key":"4225_CR29","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.4049\/jimmunol.1402898","volume":"195","author":"P Hsu","year":"2015","unstructured":"Hsu P, Santner-Nanan B, Hu M, Skarratt K, Lee CH, Stormon M, Wong M, Fuller SJ, Nanan R. Il-10 potentiates differentiation of human induced regulatory t cells via stat3 and foxo1. J Immunol. 2015;195(8):3665\u201374.","journal-title":"J Immunol"},{"issue":"1","key":"4225_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.molcel.2020.04.033","volume":"79","author":"G Toda","year":"2020","unstructured":"Toda G, Soeda K, Okazaki Y, Kobayashi N, Masuda Y, Arakawa N, et al. Insulin- and lipopolysaccharide-mediated signaling in adipose tissue macrophages regulates postprandial glycemia through akt-mtor activation. Mol Cell. 2020;79(1):43\u2013e5344.","journal-title":"Mol Cell"},{"issue":"1","key":"4225_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2020.06.016","volume":"79","author":"A Sulen","year":"2020","unstructured":"Sulen A, Aouadi M. Fed macrophages hit the liver\u2019s sweet spot with il-10. Mol Cell. 2020;79(1):1\u20133.","journal-title":"Mol Cell"},{"issue":"3","key":"4225_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","volume":"17","author":"BO Roep","year":"2021","unstructured":"Roep BO, Thomaidou S, van Tienhoven R, Zaldumbide A. Type 1 diabetes mellitus as a disease of the beta-cell (do not blame the immune system?). Nat Rev Endocrinol. 2021;17(3):150\u201361.","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"4225_CR33","first-page":"859","volume":"168","author":"JL Chiasson","year":"2003","unstructured":"Chiasson JL, Aris-Jilwan N, Belanger R, Bertrand S, Beauregard H, Ekoe JM, Fournier H, Havrankova J. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ. 2003;168(7):859\u201366.","journal-title":"CMAJ"},{"issue":"1","key":"4225_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s42003-023-05255-6","volume":"6","author":"S Norlin","year":"2023","unstructured":"Norlin S, Axelsson J, Ericsson M, Edlund H. O304 ameliorates hyperglycemia in mice by dually promoting muscle glucose effectiveness and preserving beta-cell function. Commun Biol. 2023;6(1):877.","journal-title":"Commun Biol"},{"issue":"4","key":"4225_CR35","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jhep.2007.12.017","volume":"48","author":"DE Cintra","year":"2008","unstructured":"Cintra DE, Pauli JR, Araujo EP, Moraes JC, de Souza CT, Milanski M, et al. Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol. 2008;48(4):628\u201337.","journal-title":"J Hepatol"},{"issue":"9","key":"4225_CR36","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726\u201336.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"4225_CR37","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00418-011-0908-x","volume":"137","author":"Y Yu","year":"2012","unstructured":"Yu Y, Mu J, Fan Z, Lei G, Yan M, Wang S, et al. Insulin-like growth factor 1 enhances the proliferation and osteogenic differentiation of human periodontal ligament stem cells via erk and jnk mapk pathways. Histochem Cell Biol. 2012;137(4):513\u201325.","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"4225_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/blood-2004-09-3507","volume":"106","author":"V Sordi","year":"2005","unstructured":"Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood. 2005;106(2):419\u201327.","journal-title":"Blood"},{"issue":"8","key":"4225_CR39","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/clinem\/dgad142","volume":"108","author":"A Miklosz","year":"2023","unstructured":"Miklosz A, Chabowski A. Adipose-derived mesenchymal stem cells therapy as a new treatment option for diabetes mellitus. J Clin Endocrinol Metab. 2023;108(8):1889\u201397.","journal-title":"J Clin Endocrinol Metab"},{"key":"4225_CR40","first-page":"95","volume":"205","author":"W Gepts","year":"1976","unstructured":"Gepts W. Islet changes suggesting a possible immune aetiology of human diabetes mellitus. Acta Endocrinol Suppl (Copenh). 1976;205:95\u2013106.","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"issue":"6","key":"4225_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1056\/NEJM198508083130604","volume":"313","author":"GF Bottazzo","year":"1985","unstructured":"Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, Gamble DR. In situ characterization of autoimmune phenomena and expression of hla molecules in the pancreas in diabetic insulitis. N Engl J Med. 1985;313(6):353\u201360.","journal-title":"N Engl J Med"},{"issue":"3","key":"4225_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00125-003-1089-5","volume":"46","author":"BO Roep","year":"2003","unstructured":"Roep BO. The role of t-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia. 2003;46(3):305\u201321.","journal-title":"Diabetologia"},{"issue":"2","key":"4225_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1006\/jaut.1998.0264","volume":"12","author":"A El-Sheikh","year":"1999","unstructured":"El-Sheikh A, Suarez-Pinzon WL, Power RF, Rabinovitch A. Both cd4(+)and cd8(+)t cells are required for ifn-gamma gene expression in pancreatic islets and autoimmune diabetes development in biobreeding rats. J Autoimmun. 1999;12(2):109\u201319.","journal-title":"J Autoimmun"},{"issue":"2","key":"4225_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1900\/RDS.2009.6.97","volume":"6","author":"JM Phillips","year":"2009","unstructured":"Phillips JM, Parish NM, Raine T, Bland C, Sawyer Y, De La Pena H, Cooke A. Type 1 diabetes development requires both cd4\u2009+\u2009and cd8\u2009+\u2009t cells and can be reversed by non-depleting antibodies targeting both t cell populations. Rev Diabet Stud. 2009;6(2):97\u2013103.","journal-title":"Rev Diabet Stud"},{"issue":"1","key":"4225_CR45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12022-014-9297-8","volume":"25","author":"SJ Richardson","year":"2014","unstructured":"Richardson SJ, Morgan NG, Foulis AK. Pancreatic pathology in type 1 diabetes mellitus. Endocr Pathol. 2014;25(1):80\u201392.","journal-title":"Endocr Pathol"},{"issue":"1","key":"4225_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","volume":"14","author":"S Tsalamandris","year":"2019","unstructured":"Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, Deftereos S, Tousoulis D. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol. 2019;14(1):50\u20139.","journal-title":"Eur Cardiol"},{"issue":"1","key":"4225_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1677\/JOE-08-0424","volume":"200","author":"Y Kirino","year":"2009","unstructured":"Kirino Y, Sato Y, Kamimoto T, Kawazoe K, Minakuchi K, Nakahori Y. Interrelationship of dipeptidyl peptidase iv (dpp4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and dpp4-deficient rats. J Endocrinol. 2009;200(1):53\u201361.","journal-title":"J Endocrinol"},{"issue":"4","key":"4225_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1507\/endocrj.EJ14-0584","volume":"62","author":"J Hu","year":"2015","unstructured":"Hu J, Fu Z, Chen Y, Tang N, Wang L, Wang F, Sun R, Yan S. Effects of autologous adipose-derived stem cell infusion on type 2 diabetic rats. Endocr J. 2015;62(4):339\u201352.","journal-title":"Endocr J"},{"issue":"1","key":"4225_CR49","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12020-014-0219-9","volume":"48","author":"J Hu","year":"2015","unstructured":"Hu J, Wang Y, Wang F, Wang L, Yu X, Sun R, et al. Effect and mechanisms of human wharton\u2019s jelly-derived mesenchymal stem cells on type 1 diabetes in nod model. Endocrine. 2015;48(1):124\u201334.","journal-title":"Endocrine"},{"issue":"6","key":"4225_CR50","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbmt.2008.01.006","volume":"14","author":"FE Ezquer","year":"2008","unstructured":"Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yanez AJ, Conget PA. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transpl. 2008;14(6):631\u201340.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"4225_CR51","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/stem.1132","volume":"30","author":"F Ezquer","year":"2012","unstructured":"Ezquer F, Ezquer M, Contador D, Ricca M, Simon V, Conget P. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore th1\/th2 balance and to modify the pancreatic microenvironment. Stem Cells. 2012;30(8):1664\u201374.","journal-title":"Stem Cells"},{"issue":"9","key":"4225_CR52","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song N, Scholtemeijer M, Shah K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci. 2020;41(9):653\u201364.","journal-title":"Trends Pharmacol Sci"},{"key":"4225_CR53","doi-asserted-by":"publisher","first-page":"631463","DOI":"10.3389\/fendo.2021.631463","volume":"12","author":"E de Klerk","year":"2021","unstructured":"de Klerk E, Hebrok M. Stem cell-based clinical trials for diabetes mellitus. Front Endocrinol (Lausanne). 2021;12:631463.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"4225_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/dom.12408","volume":"17","author":"JH Kim","year":"2015","unstructured":"Kim JH, Bae KH, Choi YK, Go Y, Choe M, Jeon YH, et al. Fibroblast growth factor 21 analogue ly2405319 lowers blood glucose in streptozotocin-induced insulin-deficient diabetic mice by restoring brown adipose tissue function. Diabetes Obes Metab. 2015;17(2):161\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"4225_CR55","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.7150\/ijbs.25026","volume":"14","author":"J Zhang","year":"2018","unstructured":"Zhang J, Weng W, Wang K, Lu X, Cai L, Sun J. The role of fgf21 in type 1 diabetes and its complications. Int J Biol Sci. 2018;14(9):1000\u201311.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"4225_CR56","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/en.2006-1168","volume":"148","author":"A Kharitonenkov","year":"2007","unstructured":"Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, Hansen BC, Shanafelt AB, Etgen GJ. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology. 2007;148(2):774\u201381.","journal-title":"Endocrinology"},{"issue":"3","key":"4225_CR57","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s12020-014-0413-9","volume":"48","author":"K Zibar","year":"2015","unstructured":"Zibar K, Blaslov K, Bulum T, Cuca JK, Smircic-Duvnjak L. Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls. Endocrine. 2015;48(3):848\u201355.","journal-title":"Endocrine"},{"issue":"9","key":"4225_CR58","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.2337\/db05-1435","volume":"55","author":"W Wente","year":"2006","unstructured":"Wente W, Efanov AM, Brenner M, Kharitonenkov A, Koster A, Sandusky GE, et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1\/2 and akt signaling pathways. Diabetes. 2006;55(9):2470\u20138.","journal-title":"Diabetes"},{"issue":"1","key":"4225_CR59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.15283\/ijsc20078","volume":"14","author":"SN Kim","year":"2021","unstructured":"Kim SN, Choi B, Lee CJ, Moon JH, Kim MK, Chung E, Song SU. Culturing at low cell density delays cellular senescence of human bone marrow-derived mesenchymal stem cells in long-term cultures. Int J Stem Cells. 2021;14(1):103\u201311.","journal-title":"Int J Stem Cells"},{"issue":"11","key":"4225_CR60","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jcyt.2022.06.006","volume":"24","author":"KN MacDonald","year":"2022","unstructured":"MacDonald KN, Hall MG, Ivison S, Gandhi S, Klein Geltink RI, Piret JM, Levings MK. Consequences of adjusting cell density and feed frequency on serum-free expansion of thymic regulatory t cells. Cytotherapy. 2022;24(11):1121\u201335.","journal-title":"Cytotherapy"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04225-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04225-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04225-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T06:31:17Z","timestamp":1741847477000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04225-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4225"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04225-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4198474\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"(1) Title of the approved project: The effect of adipose stromal vascular fractions on type 1 diabetes- induced complications by regulating PPAR-\u03b3; (2) Name of the institutional approval committee or unit: Institutional Animal Care and Use Committee of Kaohsiung Veterans General Hospital; (3) Approval number: IACUC-2408-2607-23112-NSTC (4) Date of approval: 15th Jan 2024. The authors declare that they have not use AI-generated work in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}